Works matching IS 0288-1012 AND VI 39 AND IP 3 AND DT 2020
1
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 203
- Article
2
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 199
- Article
3
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 193
- Article
4
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 187
- Article
5
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 179
- Article
6
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 175
- Article
7
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 171
- Article
8
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 167
- Article
9
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 161
- Article
10
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 155
- Article
11
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 149
- Article
12
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 143
- Article
13
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 137
- Article
14
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 133
- Article
15
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 127
- Emi Aizawa;
- Yoshinori Jinbu
- Article
16
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 105
- Article
17
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 95
- Article
18
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 121
- Yuya Yoneyama;
- Tomonori Matsuno;
- Kazunari Asano,Takafumi Satomi
- Article
19
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 113
- 小 松 知 子;
- 渡 辺 清 子;
- 浜 田 信 城;
- 片 山 幸太郎;
- 森 本 佳 成;
- 李 昌 一
- Article
20
- Oral Therapeutics & Pharmacology, 2020, v. 39, n. 3, p. 75
- Article